<DOC>
	<DOCNO>NCT01764386</DOCNO>
	<brief_summary>The purpose Phase 3b study assess effect combination therapy naltrexone SR/bupropion SR ( NB ) use conjunction comprehensive lifestyle intervention ( CLI ) manner consistent intend use marketing approval , body weight cardiovascular risk factor compare effect Usual Care subject overweight dyslipidemia and/or control hypertension obese . Subjects NB CLI group require undergo evaluation continue treatment Week 16 . Subjects discontinue full participation lose least 5 % body weight relative baseline and/or experience sustain increase blood pressure ( systolic diastolic ) ≥10 mmHg baseline . At Week 26 , subject originally assign Usual Care switch treatment NB CLI , subject assign NB CLI continue treatment duration study ( 78-weeks treatment period ) .</brief_summary>
	<brief_title>Method-of-Use Study Assessing Effect Naltrexone Sustained Release ( SR ) / Bupropion SR Body Weight Cardiovascular Risk Factors Overweight Obese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Female male , 18 60 year old Body mass index ( BMI ) ≥30 kg/m2 ≤45 kg/m2 subject uncomplicated obesity , BMI ≥27 kg/m2 ≤45 kg/m2 subject dyslipidemia and/or control hypertension History type 1 type 2 diabetes mellitus diagnosis Myocardial infarction within 6 month prior screen Angina pectoris Grade III IV per Canadian Cardiovascular Society grade scheme Clinical history large vessel cortical stroke , include ischemic hemorrhagic stroke ( i.e. , transient ischemic attack exclusionary ) History ( within last 20 year ) seizures , cranial trauma , bulimia , anorexia nervosa , condition predispose subject seizure Past plan surgical device intervention ( e.g. , gastric banding ) obesity Chronic use positive screen opioids Regular use tobacco product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>obesity , overweight</keyword>
</DOC>